Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $351K 8,283 sh | Mar 5, 2026 |
| 9 | Pfeiffer DeborahEVP & Pres, Presort Services | Grant or award | A | — 27.0K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 9 | Osben TeoChief Accounting Officer | Tax withholding | F | $32K 700 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 9 | Trzcinski Leah MarieChief Legal Officer | Tax withholding | F | $22K 406 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 9 | Vicente MonicaSVP, Chief Financial Officer | Option exercise | M | — 178 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 9 | Trzcinski Leah MarieChief Legal Officer | Grant or award | A | — 600 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 9 | Walter Eric V.Chief Financial Officer | Grant or award | A | — 54.3K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 9 | Lentz DanielCFO & COO | Tax withholding | F | $40K 13.5K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 8 | Werner Edward CooperChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $60K 209 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 8 | Kalia KumudChief Information Officer | Option exercise | M | $74K 1,000 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 8 | Williams Robert KirkChief People & Admin Officer | Tax withholding | F | $51K 954 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 7 | McNamara PeterChief Scientific Officer | Grant or award · 10b5-1 plan | A | — 23.0K sh | Mar 5, 2026 traded Mar 4, 2026 |
| 6 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $128K 2,937 sh | Mar 5, 2026 traded Mar 5, 2026 |
| 6 | Steenberge Michael AnthonyChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $11K 582 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 6 | McNamara PeterChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $41K 1,650 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 6 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $72K 1,600 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 5 | Silva Effie DSVP, General Counsel & Secy | Option exercise | M | — 151 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 5 | Werner Edward CooperChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $23K 80 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 5 | Werner Edward CooperChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $23K 80 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 5 | Werner Edward CooperChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $11K 40 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 5 | Kalia KumudChief Information Officer | Option exercise | M | — 1,000 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 5 | Kalia KumudChief Information Officer | Option exercise | M | — 10.0K sh | Mar 5, 2026 traded Mar 4, 2026 |
| 5 | Renninger RobertCHIEF FINANCIAL OFFICER | Option exercise | M | — 3,900 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 5 | Kalia KumudChief Information Officer | Option exercise | M | — 2,119 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 2 | Feeley KevinCHIEF FINANCIAL OFFICER | Grant or award | A | — 10.9K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 2 | Dechairo BryanChief Operating Officer | Grant or award | A | — 10.4K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 1 | Hopman MarkChief Commercial Officer | Open-market sale · 10b5-1 plan | SELL | $4,084 353 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 0 | McNamara PeterChief Scientific Officer | Grant or award · 10b5-1 plan | A | — 21.0K sh | Mar 5, 2026 traded Mar 4, 2026 |
| 0 | Ribeiro RamiroChief Medical Officer | Option exercise · 10b5-1 plan | M | $20K 2,438 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 0 | Ribeiro RamiroChief Medical Officer | Option exercise · 10b5-1 plan | M | — 2,438 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 0 | Bick Karen M.SVP - Chief People Officer | Tax withholding · 10b5-1 plan | F | $39K 841 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 0 | Bick Karen M.SVP - Chief People Officer | Tax withholding · 10b5-1 plan | F | $34K 733 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 65 | Musser ForySenior VP, Development | Open-market sale | SELL | $10.90M 1.00M sh | Mar 4, 2026 traded Mar 4, 2026 |
| 47 | Sorrentino CharlesDirector, Co-CIO | Open-market purchase | BUY | $300K 14.9K sh | Mar 4, 2026 traded Mar 2, 2026 |
| 44 | McMahon Stephen AEVP, Chief Customer Officer | Open-market purchase | BUY | $107K 3,000 sh | Mar 4, 2026 traded Mar 3, 2026 |
| 43 | Carlson MeganCAO and SVP, Finance | Open-market sale | SELL | $156K 42.0K sh | Mar 4, 2026 traded Mar 3, 2026 |
| 42 | Devivo JosephDirector, President & CEO | Open-market sale | SELL | $599K 161.3K sh | Mar 4, 2026 traded Mar 3, 2026 |
| 36 | Holt MichaelChief Financial Officer | Open-market purchase | BUY | $187K 1,000 sh | Mar 4, 2026 traded Mar 4, 2026 |
| 35 | Caezza NicholasDeputy General Counsel | Open-market sale | SELL | $53K 14.2K sh | Mar 4, 2026 traded Mar 3, 2026 |
| 35 | Sparks Paul EugeneDirector | Open-market purchase | BUY | $666K 29.0K sh | Mar 4, 2026 traded Mar 2, 2026 |